Investing.com - GlaxoSmithKline ADR reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
GlaxoSmithKline ADR announced earnings per share of £0.36 on revenue of £8.65B. Analysts polled by Investing.com anticipated EPS of £0.79 on revenue of £11.45B.
GlaxoSmithKline ADR shares are down 24.77% from the beginning of the year and are trading at £35.45 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
GlaxoSmithKline ADR shares gained 0.28% in pre-market trade the report.
GlaxoSmithKline ADR follows other major Healthcare sector earnings this month
GlaxoSmithKline ADR's report follows an earnings beat by J&J on October 13, who reported EPS of £2.2 on revenue of £21.08B, compared to forecasts EPS of £1.98 on revenue of £20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of £0.72 on revenue of £12.13B, compared to forecast for EPS of £0.69 on revenue of £12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar